|
|
Volumn 368, Issue 4, 2013, Pages 299-302
|
|
The future of antibiotics and resistance
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIBIOTIC AGENT;
ENZYME INHIBITOR;
MONOCLONAL ANTIBODY;
PENICILLIN DERIVATIVE;
PROBIOTIC AGENT;
ACINETOBACTER BAUMANNII;
ANIMAL USE;
ANTIBIOTIC RESISTANCE;
ANTIBIOTIC THERAPY;
BACTERIAL MUTATION;
BACTERICIDAL ACTIVITY;
BACTERIUM DETECTION;
BACTERIUM ISOLATE;
CLINICAL PRACTICE;
DISEASE TRANSMISSION;
DISINFECTION;
DRUG DELIVERY SYSTEM;
DRUG EFFICACY;
DRUG EXPOSURE;
DRUG MECHANISM;
DRUG MISUSE;
DRUG RESEARCH;
DRUG TARGETING;
DRUG USE;
GROWTH INHIBITION;
HEALTH CARE DELIVERY;
HEALTH CARE NEED;
HEALTH STATUS;
HUMAN;
IN VIVO STUDY;
INFECTION;
INFECTION CONTROL;
INFECTION PREVENTION;
INFLAMMATION;
LIVESTOCK;
MEDICAL HISTORY;
MICROBIAL GROWTH;
NONHUMAN;
ORGANISMAL INTERACTION;
PRIORITY JOURNAL;
PROKARYOTE;
PUBLIC-PRIVATE PARTNERSHIP;
REGENERATIVE MEDICINE;
SHORT SURVEY;
UNITED STATES;
|
|
EID: 84872806450
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMp1215093 Document Type: Article |
|
Times cited : (498)
|
|
References (5)
|
